REFERENCE
The Medicines and Healthcare Products Regulatory Agency.Bisphosphonates: atrial fibrillation. Drug Safety Update 1: 4, No. 12, Jul 2008
Rights and permissions
About this article
Cite this article
Bisphosphonates: MHRA informs about atrial fibrillation risk. React. Wkly. 1211, 2 (2008). https://doi.org/10.2165/00128415-200812110-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200812110-00003